United States RNAi Therapeutics for Rare Genetic Disorders Market...

aggiunto articolo blog Altre informazioni

2026-06-26 07:36:43 -

United States RNAi Therapeutics for Rare Genetic Disorders Market to Reach USD 0.70 Billion by 2034 as Precision Gene-Silencing Therapies Gain Momentum

According to a report by Intel Market Research, the United States RNAi Therapeutics for Rare Genetic Disorders Market was valued at USD 0.36 billion in 2025 and is projected to grow from USD 0.38 billion in 2026 to USD 0.70 billion by 2034, registering a CAGR of 8.9% during the forecast period. The market is experiencing robust growth due to increasing federal funding for orphan disease...

0 Commenti 0 Condivisioni 70 Visualizzazioni